1st Quarter - Report

BUCHANAN INGERSOLL & ROONEY PC for ANI PHARMACEUTICALS, INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Federal government relations service, strategy development and implementation relating to status of FDAs action with regards to the companys NDA.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Federal government relations service, strategy development and implementation relating to status of FDAs action with regards to the companys NDA.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Federal government relations service, strategy development and implementation relating to status of FDAs action with regards to the companys NDA.

LobbyistCovered position, as disclosed
TIMOTHY COSTA —
MICHAEL P STRAZZELLA —
ELIZABETH WESTBROOK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.